I'm Len Berkowitz, PA-C and co-founder of Center for Men's Health Rhode Island. I've spent 17 years treating men with BPH, erectile dysfunction, and other urologic conditions, including two years at Men's Health Boston--one of New England's highest-volume andrology centers--before opening our Providence practice in 2021. **How UroLift works:** The procedure uses permanent implants to physically hold back obstructing prostate lobes, creating an open channel through the urethra without cutting or heating tissue. Think of it like tying back curtains instead of removing them. This preservation approach typically means no ejaculatory dysfunction--a game-changer for sexually active men who can't tolerate medications like Flomax (retrograde ejaculation) or finasteride (libido issues). **Best candidates in my experience:** Men with lateral lobe obstruction, prostate volumes 30-80cc, moderate-to-severe IPSS scores (15+), and those prioritizing sexual function. I've seen guys in their 50s and 60s choose UroLift specifically to avoid the sexual side effects that torpedoed their medication trials. It's less ideal for very large glands (>100cc) or significant median lobe enlargement, where TURP or other resection procedures give better durability. **Risks and evidence:** Temporary dysuria, hematuria, and pelvic discomfort are common for 2-4 weeks post-procedure; most guys are back to normal activity within days. The L.I.F.T. study and BPH6 trial show sustained symptom improvement at 5+ years, though about 13-15% need a secondary intervention. Recovery beats TURP or laser ablation hands down--I've had patients return to work the next day, versus 1-2 weeks for more invasive options.
I'm not a medical expert, but I've spoken with men who've shared how UroLift changed their daily lives in quieter, personal ways--more sleep, less anxiety, restored intimacy. That, to me, says more than numbers. Feeling normal in your own body again is a kind of liberation too easily dismissed in charts. If I were advising someone I care about, I'd say: ask your doctor if UroLift fits your story, not just your symptoms. It seems especially meaningful for men who want relief without the side effects that can disconnect them from their identity--like loss of sexual function. Every treatment has trade-offs, but if UroLift offers lightness without cutting, that's worth understanding more deeply.
How the UroLift procedure works to relieve urinary obstruction without removing prostate tissue -UroLift (prostatic urethral lift, PUL) places small permanent implants via cystoscopy that retract/compress obstructing prostate lobes away from the urethra, widening the urethral lumen mechanically—without cutting, ablating, or removing tissue. Which patient profiles benefit most (prostate size, symptom severity, sexual function concerns) -Best suited for men with bothersome (often moderate-severe) LUTS who want symptom relief while prioritizing preservation of ejaculation/sexual function. EAU recommends PUL for men seeking ejaculatory preservation with prostates <70 mL and no middle lobe; AUA supports PUL in appropriately selected men with prostate volume <80 g and verified absence of an obstructive middle lobe. Potential risks, side effects, contraindications, and recovery considerations -Common short-term effects include dysuria, hematuria, urgency/frequency, pelvic discomfort, transient incontinence, and UTI; most are mild-moderate and typically resolve within weeks. Recovery is usually faster than TURP, with low rates of sexual side effects, but careful anatomic selection is important. The strength of clinical evidence supporting UroLift for long-term symptom relief and quality-of-life improvement -The sham-controlled L.I.F.T. trial shows durable improvements in IPSS, QoL, and Qmax through 5 years with 13.6% surgical retreatment and preservation of erectile/ejaculatory function. Systematic review (Cochrane) finds PUL is less effective than TURP for symptom/flow improvement (short and long term), with similar QoL and better ejaculatory outcomes, but some uncertainty in major adverse events and retreatment estimates. D-r Martina Ambardjieva, MD Urologist, Teaching surgery assistant, Medical expert at Invigor Medical Invigormedical.com
1 / I'm not a urologist--so I won't pretend I can speak clinically on UroLift. But I've had conversations in our spa with guests going through BPH treatments, and one of them shared how UroLift let him avoid the side effects he feared most with medication. For him, preserving sexual function and having a quick recovery made it a no-brainer. 2 / From what I've learned, UroLift seems to work best for guys with moderate prostate enlargement--not super large prostates--and who really want to avoid traditional surgery. One visitor said it felt more like getting a stent placed than having "something removed," and that clarity helped him feel less anxious going in. 3 / Safety-wise, I've heard mention of temporary discomfort--burning, urgency--but nothing long-term in the people I've met. I know some guys are nervous about side effects from meds like Flomax or Finasteride, and UroLift seems to sidestep a lot of those. 4 / The one guest who raved about it said he noticed improvement within two weeks and didn't need ongoing meds after. I haven't dug into medical journals, but that anecdotal feedback aligns with what I've heard: quicker recovery, no hospital stay, and fewer sexual side effects, which for many men makes it a life-changer.
(1) UroLift works by mechanically holding the obstructing prostate lobes apart, creating a wider channel in the urethra without cutting, heating, or removing tissue. This reduces resistance to urinary flow while avoiding the risks of thermal-based destruction common with TURP or laser therapies. According to published studies, it preserves the integrity of surrounding structures--especially nerves linked to sexual function. (2) We've seen UroLift used most effectively in men with moderate lower urinary tract symptoms, prostate volumes under 80cc, and a strong desire to avoid sexual side effects. It's often a good option when first-line medications are poorly tolerated or ineffective. In patients with larger prostates or a high bladder neck, surgical or laser-based interventions may be more appropriate. (3) Risk profile is relatively favorable--most common side effects include temporary hematuria, dysuria, and urgency, typically resolving within two weeks. It's an outpatient procedure, often under local anesthesia, with fast return to normal activity. That said, UroLift isn't well suited for men with a median lobe obstruction or significant bladder dysfunction, so pre-op evaluations (e.g., cystoscopy, urodynamics) are key. (4) Long-term data from studies like the L.I.F.T. trial have shown sustained symptom improvement through five years, with a lower rate of retreatment compared to medications and fewer complications than resective surgery. Compared to alpha-blockers or 5-ARIs, UroLift offers faster relief without ongoing pharmaceutical side effects, but success hinges on careful patient selection and operator experience. Happy to share additional insight from a systems design perspective--treatments like this highlight how simplicity combined with anatomical precision can meaningfully shift outcomes without escalating risk.
Founder & Medical Director at New York Cosmetic Skin & Laser Surgery Center
Answered 3 months ago
I'm Dr. Cameron Rokhsar, a board certified dermatologist in New York, and I often counsel men who worry about sexual side effects when they are sent for BPH care. UroLift is appealing because it opens the channel by pinning obstructing prostate lobes apart with small implants, not by cutting or heating tissue. When I read the long follow up data, what stood out was durability with function. One report summarizes sustained improvements of about 36% in symptom score, 50% in quality of life, and a 44% rise in peak flow over five years. For patient fit, I tell men to ask their urologist if they have mainly lateral lobe obstruction and want ejaculation preserved. That same summary notes a low surgical retreatment rate around 2 to 3% per year. Risks are usually short lived urinary burning, blood in urine, pelvic discomfort, UTI, or transient urgency. Contraindications depend on anatomy and infection status, so selection matters.